Clean hands save lives - Wash your hands!
SPRAVATO®
Exciting News: SPRAVATO® Treatments Available!
We are particularly excited to begin offering SPRAVATO® treatments for qualifying individuals!
SPRAVATO® (also known as intranasal ketamine or Esketamine Nasal Spray) was approved by the FDA in 2019 as an antidepressant therapy.
This medication is delivered as a self-administered nasal spray, similar to metered nasal sprays commonly used for allergy treatments.
In early 2025, SPRAVATO® was approved as a monotherapy, which means it can effectively treat depression without requiring other traditional antidepressant therapies.
Our Mission
Our mission is to provide safe, compassionate, and effective treatment to the best of our abilities while using IV Ketamine infusions in conjunction with your traditional therapies and psychiatric treatments to manage a myriad of mood disorders shown to benefit.
FAQ:
Is SPRAVATO® Covered by Insurance?:
YES! Most insurances accept Spravato® although sometimes a small copayment is required. Our skilled team will work with you to secure prior authorization and benefits eligibility, which usually takes around 1-2 weeks. Once prior authorization is secured, we can begin treatments at our clinic.
How Often Are These Treatments Needed?:
-
For the first two weeks, treatments will be administered twice weekly spaced every couple of days.
-
For the next 4 weeks, treatments are administered once weekly.
-
Thereafter, treatments are given anywhere from every 2 weeks to once monthly based upon response and need.
The average treatment time is 4.5 years (although some continue indefinitely).
Can I Drive Myself?:
SPRAVATO® is a CIII controlled substance known to impair driving for several hours. Therefore, a chaperone will be required for a ride home, and driving is discouraged for at least 6 hours.
How Long Does Each Treatment Last?:
These treatments are monitored through a government sponsored program called REMS (Risk Evaluation and Mitigation Strategies). There are several requirements to ensure the proper and safe management of this medication. One of the requirements is that patients must be monitored for 2 hours after the last spray administered (so each visit will take approximately 135-145 minutes from start to finish.
Contraindications to Treatment:
Pregnancy
Schizophrenia (Schizoaffective Disorder)
(or Family history of Schizophrenia)
Mania
Active Alcohol or Substance Abuse
Previous hypersensitivity to Ketamine
Do I Need a Referral?:
Most insurance companies require a referral from your Family Doctor (PCP), and many require a "Letter of Medical Necessity" from your psychiatric provider. If you think this treatment is right for you, please discuss with your doctor and/or click the link to BOOK A SESSION NOW!
Where Can I Learn More About SPRAVATO®?:
Follow this link to the SPRAVATO® website: